Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients (RECAD-AF)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Brent Wilson, University of Utah
ClinicalTrials.gov Identifier:
NCT01710254
First received: October 2, 2012
Last updated: November 1, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2016
  Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)